Building best practice in clinical pharmacy
ESCP recognises that the translation of academic evidence into day-to-day practice is an important step in the development of clinical pharmacy services – and ESCP Best Practice papers… read more.
ESCP recognises that the translation of academic evidence into day-to-day practice is an important step in the development of clinical pharmacy services – and ESCP Best Practice papers… read more.
ESCP is a dynamic organisation that responds to the needs of its members and in doing so it has undertaken a number of key developments in recent years,… read more.
‘Innovations in Clinical Pharmacy Practice, Education and Research’ will be the topic of the forthcoming ESCP Symposium, to be held in Aberdeen, Scotland in Autumn 2023. IMI spoke… read more.
Pharmacogenomics and personalised medicine are increasingly becoming a part of mainstream healthcare and it is an area where pharmacists have a major part to play. In this series… read more.
Recent research has demonstrated the value of pharmacogenomics-guided prescribing but this is a far cry from the implementation of routine services. Dr Raliate Onatade Chief Pharmacist for North… read more.
A number of examples show how pharmacogenetic testing is being integrated into day-to-day practice and helping to improve the safe and effective use of medicines, Raliat Onatade, Chief… read more.
Raliat Onatade, Chief Pharmacist for North Thames Genomic Medicines Service Alliance, recently gave the opening keynote address at the EAHP Congress in Lisbon (March 2023) on the subject… read more.
A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.
The management of heart failure treatment is probably best done by a primary care team and pharmacists can play a major role in prescribing, says Paul Forsyth, Lead… read more.
The key challenges in heart failure treatment include reaching the target dose, awareness of drug-specific issues that influence effectiveness and tackling adherence problems, according to Paul Forsyth, Lead… read more.
Current thinking advocates the use of ‘four pillars of heart failure therapy’. Paul Forsyth, Lead Pharmacist, Clinical Cardiology at NHS Greater Glasgow and Clyde, explains how this treatment… read more.
A recent publication described the holistic approach to drug therapy in a patient with heart failure – an area where treatment has changed considerably over the past 30… read more.